Joey Bada$$ Believes the Media is ‘Brainwashing’ People About Bill Cosby Rape Allegationsīen Rappaport and Tom Riis Farrell will also reprise their roles as Angela’s ex, Ollie, and Bill this season. Today, he serves as an executive of his own Pro Era record label. He often talks excessively to Elliot, advising him and philosophizing the meanings of life.Īfter releasing several acclaimed mixtapes, Joey released his debut album last year, which became the most successful independent hip-hop release of 2015. Joey Bada$$ (real name Jo-Vaughn Virginie Scott) will play a new close friend of Elliot’s from the neighborhood. The Grief of Others and Two Night Stand actor is repped by Gersh. Their moments of intimacy leave the young, attractive Derek infatuated with her. The actress, whose other credits include Legends of Tomorrow and American Horror Story: Asylum, is repped by Independent Talent Group, PCM International and Lichter Grossman.Īfter severing ties with her husband in season one, Joanna will now have a new man in her life, Derek, played by Conroy. The collaboration with Profound in MR-guided ultrasound ablation therapy complements Philips’ product portfolio, collaborations and R&D programs in MR-guided radiation therapy.Corneliussen made a memorable turn in season one as Tyrell Wellick’s smart and ruthless wife Joanna, who is willing to do whatever it takes to put her family in a position of power. The transaction is subject to customary closing conditions, including the relevant regulatory approvals, and is expected to close in the second half of 2017. The agreement also includes a deferred cash payment that will depend on the achievement of future Profound revenue levels in the period up to and including 2020. By leveraging MR-guidance and ultrasound to deliver incision-free, personalized, precise and cost-effective therapeutic solutions, I believe we are well on our way to realize that vision.”Īs part of the agreement, Philips will obtain 7,400,000 Profound common shares representing a minority interest of approximately 12 percent based on the issued and outstanding Profound shares upon completion of the transaction. “At Profound, we envision a world where patients can undergo clinically effective procedures and return quickly to their normal lives. “This agreement with Philips is in line with our commitment to invest in the powerful combination of real-time MR-guidance as the imaging platform and ultrasound as the energy source for delivering non-invasive ablative technology to clinicians and their patients,” said Dr. We believe that the increased scale of the business as a result of the transfer of Philips’ MR-HIFU activities to Profound and the resulting enhanced close collaboration will accelerate the development of new clinical applications for this promising technology, while better serving the needs of our current and future MR-HIFU customers.” “We recognize the broader value MR-guided HIFU therapies can bring to clinicians and their patients, and we appreciate Profound’s strengths in the area of MR-guided ultrasound ablation therapy. “We strive to provide clinicians with a broad portfolio of targeted therapy solutions for the treatment of complex diseases such as cancer,” said Rob Cascella, Chief Business Leader Diagnosis and Treatment at Royal Philips. Philips is already non-exclusively distributing Profound’s TULSA-PRO ® system, which is specifically designed for MR-guided prostate tissue ablation procedures. Philips will continue to distribute Sonalleve for use in combination with its Philips Ingenia and Achieva MR imaging systems, and Philips will provide additional services to Profound including manufacturing of the MR-HIFU table and installation services. Sonalleve is CE-marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Philips’ Sonalleve MR-HIFU is a therapeutic device that is used in conjunction with real-time MR imaging and thermometry to enable focused, non-invasive ablation of diseased tissue. As part of the agreement, Philips’ MR-HIFU business will be transferred to Profound, a leader in MR-guided ultrasound ablation therapies, while Philips will obtain a minority interest in Profound. Amsterdam, The Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has entered into an agreement with Profound Medical Corp. (TSXV: PRN, OTCQX: PRFMF) to deepen the existing collaboration and increase the scale of its MR-guided High Intensity Focused Ultrasound (HIFU) business.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |